Literature DB >> 28365578

Patients with Early Rheumatoid Arthritis in the 2000s Have Equal Disability and Pain Despite Less Disease Activity Compared with the 1990s: Data from the BARFOT Study over 8 Years.

Maria L E Andersson, Kristina Forslind, Ingiäld Hafström.   

Abstract

OBJECTIVE: To compare outcomes over the first 8 years in patients with early rheumatoid arthritis (RA) recruited in the 1990s and the 2000s, with a special focus on functional disability and its possible predictors.
METHODS: Data were acquired from 1938 patients with early RA (American College of Rheumatology 1987 criteria) included in the BARFOT study, who had completed the 8-year followup. The patients were divided into 2 cohorts: cohort 1 (n = 928, 68% women) included from 1992 to 1999 and cohort 2 (n = 1010, 70% women) included from 2000 to 2006. Health Assessment Questionnaire (HAQ), 28-joint Disease Activity Score (DAS28), visual analog scale pain, and radiographs of hands and feet scored by the van der Heijde modified Sharp method were assessed during the 8 years. Longitudinal data analyses were performed using a generalized linear model.
RESULTS: Despite more active medical treatment during the 2000s, the courses of HAQ and pain showed no difference between the cohorts during followup, in either women or in men, with significantly higher levels in women compared with men. However, as expected, disease activity decreased more over time in cohort 2 compared with cohort 1, for both sexes, and women in cohort 2 had less radiographic progression compared with cohort 1. HAQ was associated with DAS28, pain, radiological scores, and sex in both cohorts, and in cohort 2 also with age and smoking.
CONCLUSION: Patients included in the 2000s had lower disease activity, but not less activity limitation and pain over 8 years of followup despite more active treatment. Pain, aging, and smoking might explain why patients included in the 2000s still had the same disability levels as those included in the 1990s.

Entities:  

Keywords:  DISEASE ACTIVITY; EARLY RHEUMATOID ARTHRITIS; HEALTH ASSESSMENT QUESTIONNAIRE; PAIN

Mesh:

Substances:

Year:  2017        PMID: 28365578     DOI: 10.3899/jrheum.161235

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  17 in total

1.  Rheumatoid arthritis: The benefits of early treatment after decades.

Authors:  Angela Zink; Katinka Albrecht
Journal:  Nat Rev Rheumatol       Date:  2017-06-29       Impact factor: 20.543

Review 2.  Global epidemiology of rheumatoid arthritis.

Authors:  Axel Finckh; Benoît Gilbert; Bridget Hodkinson; Sang-Cheol Bae; Ranjeny Thomas; Kevin D Deane; Deshiré Alpizar-Rodriguez; Kim Lauper
Journal:  Nat Rev Rheumatol       Date:  2022-09-06       Impact factor: 32.286

3.  Trends in Prevalence of Functional Disability in Rheumatoid Arthritis Compared With the General Population.

Authors:  Elena Myasoedova; John M Davis; Sara J Achenbach; Eric L Matteson; Cynthia S Crowson
Journal:  Mayo Clin Proc       Date:  2019-05-01       Impact factor: 7.616

4.  Association of Disease Activity and Disability With Rehabilitation Utilization in African American Adults With Rheumatoid Arthritis.

Authors:  Louise M Thoma; Rebecca J Cleveland; Beth L Jonas; S Louis Bridges; Leigh F Callahan
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-01       Impact factor: 4.794

5.  Is Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis Still a More Severe Disease Than Anti-Citrullinated Protein Antibody-Negative Rheumatoid Arthritis? A Longitudinal Cohort Study in Rheumatoid Arthritis Patients Diagnosed From 2000 Onward.

Authors:  Aleid C Boer; Annelies Boonen; Annette H M van der Helm van Mil
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-05-28       Impact factor: 4.794

6.  European Qualitative research project on Patient-preferred outcomes in Early Rheumatoid Arthritis (EQPERA): rationale, design and methods of a multinational, multicentre, multilingual, longitudinal qualitative study.

Authors:  Kristien Van der Elst; Ann Bremander; An De Groef; Ingrid Larsson; Elke G E Mathijssen; Johanna E Vriezekolk; Rene Westhovens; Yvonne J L van Eijk-Hustings
Journal:  BMJ Open       Date:  2019-03-27       Impact factor: 2.692

7.  Influence of Age and Sex on Disease Course and Treatment in Rheumatoid Arthritis.

Authors:  Monica Leu Agelii; Inger Gjertsson; Jenny Nilsson; Maria L E Andersson; Ingiäld Hafström; Björn Svensson; Kristina Forslind; Sofia Ajeganova
Journal:  Open Access Rheumatol       Date:  2021-05-24

8.  Distribution of erosions in hands and feet at the time for the diagnosis of RA and during 8-year follow-up.

Authors:  Maria L Andersson; B Svensson; K Forslind
Journal:  Clin Rheumatol       Date:  2020-10-23       Impact factor: 2.980

9.  Unmet Needs in the Treatment of RA in the Era of Jak-i: IDRA (Italian Delphi Rheumatoid Arthritis) Consensus.

Authors:  R Caporali; A Doria; G F Ferraccioli; P L Meroni; D Zavaglia; F Iannone
Journal:  Biomed Res Int       Date:  2018-09-09       Impact factor: 3.411

10.  Exploring the transcriptome of resident spinal microglia after collagen antibody-induced arthritis.

Authors:  Teresa Fernandez-Zafra; Tianle Gao; Alexandra Jurczak; Katalin Sandor; Zoe Hore; Nilesh M Agalave; Jie Su; Johanna Estelius; Jon Lampa; Tomas Hokfelt; Zsuzsanna Wiesenfeld-Hallin; Xiaojun Xu; Franziska Denk; Camilla I Svensson
Journal:  Pain       Date:  2019-01       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.